Comparison of ondansetron with metoclopramide in treatment of nausea and vomiting

Comparison of ondansetron with metoclopramide in treatment of PONV

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0004721

Enrollment

800

Registered

2020-02-10

Start date

2020-03-02

Completion date

Unknown

Last updated

2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : ondansetron 1 mg, metoclopramide 5 mg, metoclopramide 10 mg, single bolus intravenous injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients undergoing elective general anesthesia

Exclusion criteria

Exclusion criteria: 1. Patients have known side effects to ondansetron or metoclopramide 2. Communication difficulty 3. Higher than American Society of Anesthesiologists physical status 3 4. Cerebral disease 5. Epilepsy 6. Pheochromocytoma 7. Depression 8. Parkinson's disease 9. Somach surgery 10. Pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
Efficacy of treatment to PONV	—

Secondary

Measure	Time frame
Side effects	—

Countries

Korea, Republic of

Contacts

Public ContactSeonghoon Ko

Chonbuk National University

Outcome results